|
Goodwill and Intangible Assets (Tables)
|
6 Months Ended |
|
Mar. 30, 2013
|
| Goodwill And Intangible Assets Disclosure [Abstract] |
|
| Rollforward of Goodwill Activity by Reportable Segment |
A rollforward
of goodwill activity by reportable segment from September 29,
2012 to March 30, 2013 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Breast Health |
|
|
Diagnostics |
|
|
GYN Surgical |
|
|
Skeletal Health |
|
|
Total |
|
|
Balance at
September 29, 2012
|
|
$ |
635,741 |
|
|
$ |
2,283,447 |
|
|
$ |
1,015,466 |
|
|
$ |
8,125 |
|
|
$ |
3,942,779 |
|
|
Gen-Probe acquisition
adjustments
|
|
|
— |
|
|
|
(2,146 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2,146 |
) |
|
Chindex
acquisition
|
|
|
1,903 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,903 |
|
|
Tax adjustments
|
|
|
— |
|
|
|
(545 |
) |
|
|
12 |
|
|
|
— |
|
|
|
(533 |
) |
|
Foreign currency
|
|
|
(1,614 |
) |
|
|
255 |
|
|
|
666 |
|
|
|
(1 |
) |
|
|
(694 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 30,
2013
|
|
$ |
636,030 |
|
|
$ |
2,281,011 |
|
|
$ |
1,016,144 |
|
|
$ |
8,124 |
|
|
$ |
3,941,309 |
|
|
| Intangible Assets |
Intangible Assets
Intangible assets consisted
of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description
|
|
As of March
30, 2013 |
|
|
As of September 29, 2012 |
|
| |
Gross
Carrying
Value |
|
|
Accumulated
Amortization |
|
|
Gross
Carrying
Value |
|
|
Accumulated
Amortization |
|
|
Developed technology
|
|
$ |
3,816,465 |
|
|
$ |
938,655 |
|
|
$ |
3,784,689 |
|
|
$ |
788,274 |
|
|
In-process research and
development
|
|
|
193,000 |
|
|
|
— |
|
|
|
227,000 |
|
|
|
— |
|
|
Customer relationships and
contracts
|
|
|
1,101,232 |
|
|
|
250,972 |
|
|
|
1,097,842 |
|
|
|
205,612 |
|
|
Trade names
|
|
|
238,077 |
|
|
|
72,027 |
|
|
|
240,092 |
|
|
|
60,318 |
|
|
Patents
|
|
|
11,940 |
|
|
|
8,109 |
|
|
|
11,417 |
|
|
|
7,906 |
|
|
Business
licenses
|
|
|
2,607 |
|
|
|
478 |
|
|
|
2,577 |
|
|
|
344 |
|
|
Non-competition
agreements
|
|
|
306 |
|
|
|
270 |
|
|
|
310 |
|
|
|
223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
$ |
5,363,627 |
|
|
$ |
1,270,511 |
|
|
$ |
5,363,927 |
|
|
$ |
1,062,677 |
|
|
| Estimated Remaining Amortization Expense |
The estimated remaining
amortization expense as of March 30, 2013 for each of the five
succeeding fiscal years was as follows:
|
|
|
|
|
|
Remainder of Fiscal
2013
|
|
$ |
205,733 |
|
|
Fiscal 2014
|
|
|
398,978 |
|
|
Fiscal 2015
|
|
|
384,088 |
|
|
Fiscal 2016
|
|
|
370,306 |
|
|
Fiscal 2017
|
|
|
361,254 |
|
|